Drug Topics

SEPTEMBER 20, 2023

Suicides among health care professionals are estimated to occur at a higher rate than in the general public.

220

220

Pharmacy Times

SEPTEMBER 20, 2023

Investigators of the GLAAD and Gilead COMPASS Initiative survey tracked the progress against HIV stigma, the transmission and prevention of HIV, and the attitudes and knowledge of those living with HIV in the United States.

139

139

Drug Topics

SEPTEMBER 20, 2023

A study found that the 3 leading cell type therapies used to treat COVID-19 were mesenchymal stem cells or multipotent stromal cells, natural killer cells, and mononuclear cells.

131

131

Pharmacy Times

SEPTEMBER 20, 2023

Dapo Amosu, MS, PharmD, DPLA, discusses his thoughts on how to advance medication use processes in inpatient and ambulatory settings and the role of the pharmacist in this endeavor.

139

139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 20, 2023

The federal government is again offering free Covid-19 tests to Americans, providing a fifth round of free tests in part to meet current needs, in part to stimulate a domestic testing industry that has struggled with cratering demand for the rapid diagnostics. The measure, announced Wednesday, will see rapid tests released from the Strategic National Stockpile.

145

145

Drug Topics

SEPTEMBER 20, 2023

The Ohio Board of Pharmacy found during several inspections that some CVS stores in the state had dirty conditions, a lack of control over dangerous medications, and months-long wait times for medications.

112

112

Fierce Healthcare

SEPTEMBER 20, 2023

Traditional Medicare not only doesn’t measure up to Medicare Advantage (MA) when it comes to cutting back on utilization, it also falls short in many ways compared to commercial insurance for those | Researchers say Medicare Advantage enrollees have more than 50% fewer inpatient hospital stays than FFS Medicare enrollees and 22% fewer visits to emergency departments.

Insurance 134

Insurance Hospitals 134

STAT

SEPTEMBER 20, 2023

Open wide, AI wants a look inside your mouth. A new wave of software is promising to supercharge dentists’ ability to spot decay and bone loss — and propose treatments earlier in the disease process. In just the past three years, eight AI products have gained approval from the Food and Drug Administration. Many more are on the way. These tools in some cases identify lesions years before dentists can see them on X-rays and other images, providing increased treatment opportunities ba

144

144

Fierce Healthcare

SEPTEMBER 20, 2023

Amid a flurry of partisan roadblocks rolling out across Capitol Hill, representatives on both sides of the aisle came together Tuesday to critique federal agencies’ rollout of the No Surprises Act | Members of the House's Ways and Means Committee were unified in their critiques of HHS' "flawed implementation" of their bipartisan consumer protection legislation.

134

134

STAT

SEPTEMBER 20, 2023

As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. for selling unapproved versions of its Mounjaro diabetes drug, which is frequently used for combating obesity. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding 139

Compounding Compounding Pharmacies 139

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

SEPTEMBER 20, 2023

If taking tenofovir alafenamide fumarate, a close monitoring of blood pressure and lipid levels are essential due to greater risk of hypertension.

139

139

STAT

SEPTEMBER 20, 2023

T wo months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he has championed for some time — awarding prizes, instead of patents, for inventing medicines. A measure was passed directing the National Academies of Sciences, Engineering, and Medicine to study the idea and was added to the Pandemic and All-Hazards Preparedness Act.

138

138

Fierce Healthcare

SEPTEMBER 20, 2023

As pharmacy benefit managers and drug manufacturers once again sparred on the Hill, a group of transparent PBMs revealed that they had come together to form a coalition that drives industry reform. | As pharmacy benefit managers and drug manufacturers once again sparred on the Hill, a group of transparent PBMs revealed they had come together to form a coalition that drives industry reform.

131

131

STAT

SEPTEMBER 20, 2023

Difficulty scheduling an urgent or time-sensitive appointment is now the most common gripe my patients sound off about to my primary care colleagues and me. Our practice is not the exception — it has become the rule. A 2022 national survey showed that, on average, it takes 20.6 days to get a family medicine appointment. There are many reasons for this, including, most significantly, a shorthanded clinician workforce, with many physicians either leaving primary care or opting for models li

Medical Schools 135

Medical Schools 135

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

SEPTEMBER 20, 2023

American Physician Partners, a Brentwood, Tennessee-based hospital staffing firm, announced Tuesday that it and its affiliates have filed for Chapter 11 bankruptcy protections “to complete the orde | The company said it has wound down over 150 contracts in July and attributed its financial difficulties to the pandemic and the No Surprises Act.

Hospitals 126

Hospitals 126

STAT

SEPTEMBER 20, 2023

ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set back with the agency requesting an additional study. Neffy, as the product is called, is a nasal spray that delivers the same drug, epinephrine, as the auto-injectors currently used to treat anaphylaxis.

FDA 130

FDA 130

Fierce Healthcare

SEPTEMBER 20, 2023

Cardiologists running independent practices face an increasingly complex operating environment with new payment models, fragmented technology, resource shortages and administrative burnout. | CardioOne is a care delivery enablement platform that works with independent cardiology practices to help them shift to value-based care. The startup inked new partnerships and nabbed $8 million in seed funding to fuel its growth.

124

124

STAT

SEPTEMBER 20, 2023

Apellis Pharmaceuticals has been slowly rebounding from an unjustified safety scare related to its approved treatment for a common type of vision loss. Now, a competing medicine from Astellas, also recently approved, may have stumbled, which could further boost Apellis’ business outlook — and its stock price. In a statement released Monday night, Astellas announced the “positive” outcome of an important follow-up analysis meant to demonstrate the two-year efficacy of

127

127

Drug Topics

SEPTEMBER 20, 2023

The phase 3 LIBERTY ASTHMA VOYAGE clinical trial was conducted with the purpose of investigating the effects of the investigational drug and discovering whether it would be a promising option.

98

98

STAT

SEPTEMBER 20, 2023

Americans who suffer severe allergic reactions won’t have alternatives to autoinjectors like the Epipen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy , an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or h

FDA 121

FDA 121

Fierce Pharma

SEPTEMBER 20, 2023

After a manufacturing-related complete response letter held up the U.S. | UCB had previously expected an FDA decision during the first half of the year after suffering a prior rejection on its medicine. But now the company warned a decision will likely be delayed past the third quarter.

FDA 121

FDA 121

STAT

SEPTEMBER 20, 2023

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI , they say. In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electro

117

117

Fierce Pharma

SEPTEMBER 20, 2023

Positive FDA advisory committee votes aren’t always a blueprint for approval. | Positive FDA advisory committee votes aren’t always a blueprint for approval. ARS Pharmaceuticals learned that lesson the hard way, as the FDA issued a surprise rejection of its anaphylaxis nasal spray Neffy.

FDA 121

FDA 121

Pharmacy Times

SEPTEMBER 20, 2023

Despite this decision, the trend of various states attempting to regulate pharmacy benefit managers is expected to continue

132

132

Fierce Pharma

SEPTEMBER 20, 2023

With the surge in demand for GLP-1 diabetes and weight loss drugs—and companies struggling to supply them—it was only a matter of time before knockoffs reached the market. | Early this summer, Novo Nordisk filed multiple lawsuits accusing companies of producing and selling compounded versions of Ozempic and Wegovy. Now, Eli Lilly has done the same, filing eight separate complaints in five states.

Compounding 115

Compounding 115

Pharmacy Times

SEPTEMBER 20, 2023

The TJC and IHI advocate for medication reconciliation at all transitions of care.

156

156

STAT

SEPTEMBER 20, 2023

For the fourth time this year, Novartis has been reprimanded by a U.K. trade group for misleading promotional efforts for its biggest-selling drug and, in the process, failing to maintain high standards expected of pharmaceutical companies. In the latest instance, the company was cited for hosting an online event to discuss heart failure but the virtual meeting essentially amounted to a promotional event, since Novartis medicines — specifically, the Entresto heart failure treatment ȁ

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies 110

PharmExec

SEPTEMBER 20, 2023

The current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.

Vaccines 108

Vaccines 108

STAT

SEPTEMBER 20, 2023

The small box full of promises arrived at Jessica Anderson’s home on her 31st birthday. A little bigger than a postcard, it was white with green lettering and navy and fuchsia flourishes. She opened it and pulled out a card with pills arrayed in plastic bubbles, coral ones for the morning, baby-blue for the evening. The culmination of decades of research, a reservoir of hope for thousands, these oblong tablets were supposed to transform her life, a life circumscribed by illness and the sp

106

106

Digital Pharmacist

SEPTEMBER 20, 2023

The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Every year, the enrollment period runs from October 15 to December 7. This leaves very little time before patients need to re-evaluate their insurance. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.

Independent Pharmacies 105

Independent Pharmacies Insurance Nursing Homes Immunization 105

Pharmaceutical Technology

SEPTEMBER 20, 2023

The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.

129

129

STAT

SEPTEMBER 20, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.

103

103

Drug Store News

SEPTEMBER 20, 2023

Total Halloween spending is expected to reach a record $12.2 billion, topping last year’s record of $10.6 billion and also exceeding pre-pandemic levels.

111

111

STAT

SEPTEMBER 20, 2023

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is chocolate raspberry — and get started. To help you along, we have assembled another menu of tidbits for you to peruse.

Compounding 97

Compounding Compounding Pharmacies FDA 97